Literature DB >> 8966605

Role of beta-chemokines in suppressing HIV replication.

C E Mackewicz, E Barker, J A Levy.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8966605     DOI: 10.1126/science.274.5291.1393

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  22 in total

1.  Do beta-chemokines have clinical relevance in HIV infection?

Authors:  C E Mackewicz; E Barker; G Greco; G Reyes-Teran; J A Levy
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Abrogation of in vitro suppression of human immunodeficiency virus type 1 (HIV-1) replication mediated by CD8+ T lymphocytes of asymptomatic HIV-1 carriers by staphylococcal enterotoxin B and phorbol esters through induction of tumor necrosis factor alpha.

Authors:  M Kubo; T Ohashi; M Fujii; S Oka; A Iwamoto; S Harada; M Kannagi
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 3.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

4.  Expression of macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response.

Authors:  C Trumpfheller; K Tenner-Racz; P Racz; B Fleischer; S Frosch
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

5.  CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.

Authors:  S Le Borgne; M Février; C Callebaut; S P Lee; Y Rivière
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors.

Authors:  Carl E Mackewicz; Charles S Craik; Jay A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-06       Impact factor: 11.205

7.  Induction of a Soluble Anti-HIV-1 factor (s) with IFN-γ, IL-10, and β-Chemokine Modulating Activity by an Influenza-Bacterial Polyantigenic Mixture.

Authors:  José W Rodríguez; Nat O Pagan; María C Ocasio; Zilka Ríos; Luis A Cubano; Nawal M Boukli; Miguel Otero; Robert Hunter; Madhavan P Nair; Eddy Rios-Olivares
Journal:  Am J Infect Dis       Date:  2007

8.  HIV-1-suppressive factors are secreted by CD4+ T cells during primary immune responses.

Authors:  Sayed F Abdelwahab; Fiorenza Cocchi; Kenneth C Bagley; Roberta Kamin-Lewis; Robert C Gallo; Anthony DeVico; George K Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

9.  Persistently HIV-1 seronegative Nairobi sex workers are susceptible to in vitro infection.

Authors:  D Bienzle; K S Macdonald; K F Copeland; J J Bwayo; F A Plummer; K L Rosenthal
Journal:  Can J Infect Dis       Date:  2000-09

Review 10.  Human immunodeficiency virus vaccine trials.

Authors:  Robert J O'Connell; Jerome H Kim; Lawrence Corey; Nelson L Michael
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.